Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bladder preserving approach for muscle invasive bladder cancer--role of mycobacterium w.

Literature DB >> 15168998

Bladder preserving approach for muscle invasive bladder cancer--role of mycobacterium w.

Prabir Chaudhuri¹, Sharadwat Mukhopadhyay.

Abstract

Mycobacterium w (immuvac), a new potent immunomodulator was evaluated as concomitant therapy in the management of muscle invasive bladder cancer along with external beam radiation therapy. There was no residual tumour in all the five patients after two months of therapy. All patients remained disease free for an observation period of more than 2 years.

Entities: Disease Species

Mesh：

Substances：

Year: 2003 PMID： 15168998

Source DB: PubMed Journal: J Indian Med Assoc ISSN： 0019-5847

Keyword Cloud
Cited

14 in total

1. Outcomes of toll-like receptors' antagonism in steroid-resistant optic neuritis; a pilot study.

Authors: Aditya Sudhalkar; Mayuri Khamar; Bakulesh Khamar
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-12-15 Impact factor: 3.117

Review 2. Human Bacterial Repertoire of the Urinary Tract: a Potential Paradigm Shift.

Authors: Aurélie Morand; Florent Cornu; Jean-Charles Dufour; Michel Tsimaratos; Jean-Christophe Lagier; Didier Raoult
Journal: J Clin Microbiol Date: 2019-02-27 Impact factor: 5.948

3. Mycobacterium W administration for steroid resistant optic neuritis with long-term follow-up.

Authors: Aditya Sudhalkar; Mayuri Khamar; Bakulesh Khamar
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2014-09-18 Impact factor: 3.117

4. Trial Watch: Experimental Toll-like receptor agonists for cancer therapy.

Authors: Lorenzo Galluzzi; Erika Vacchelli; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal: Oncoimmunology Date: 2012-08-01 Impact factor: 8.110

5. Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice.

Authors: Faiz Ahmad; Jiju Mani; Pawan Kumar; Seenu Haridas; Pramod Upadhyay; Sangeeta Bhaskar
Journal: PLoS One Date: 2011-09-30 Impact factor: 3.240

Bladder preserving approach for muscle invasive bladder cancer--role of mycobacterium w.

1. Outcomes of toll-like receptors' antagonism in steroid-resistant optic neuritis; a pilot study.

Review 2. Human Bacterial Repertoire of the Urinary Tract: a Potential Paradigm Shift.

3. Mycobacterium W administration for steroid resistant optic neuritis with long-term follow-up.

4. Trial Watch: Experimental Toll-like receptor agonists for cancer therapy.

5. Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice.

6. Mycobacterium indicus pranii supernatant induces apoptotic cell death in mouse peritoneal macrophages in vitro.

7. Molecular analysis of a leprosy immunotherapeutic bacillus provides insights into Mycobacterium evolution.

8. Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine.

9. Polyphasic taxonomic analysis establishes Mycobacterium indicus pranii as a distinct species.

10. Synergistic activation of innate and adaptive immune mechanisms in the treatment of gonadotropin-sensitive tumors.